Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis.

MLA

Andia, Marcelo E., et al. “Fibrin-Targeted Magnetic Resonance Imaging Allows in Vivo Quantification of Thrombus Fibrin Content and Identifies Thrombi Amenable for Thrombolysis.” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, no. 6, June 2014, pp. 1193–98. EBSCOhost, https://doi.org/10.1161/ATVBAHA.113.302931.

APA

Andia, M. E., Saha, P., Jenkins, J., Modarai, B., Wiethoff, A. J., Phinikaridou, A., Grover, S. P., Patel, A. S., Schaeffter, T., Smith, A., & Botnar, R. M. (2014). Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(6), 1193–1198. https://doi.org/10.1161/ATVBAHA.113.302931

Chicago

Andia, Marcelo E, Prakash Saha, Julia Jenkins, Bijan Modarai, Andrea J Wiethoff, Alkystis Phinikaridou, Steven P Grover, et al. 2014. “Fibrin-Targeted Magnetic Resonance Imaging Allows in Vivo Quantification of Thrombus Fibrin Content and Identifies Thrombi Amenable for Thrombolysis.” Arteriosclerosis, Thrombosis, and Vascular Biology 34 (6): 1193–98. doi:10.1161/ATVBAHA.113.302931.